Comorbid obesity and sleep apnea treatment preferences found to differ among patients and providers

Comorbid obesity and sleep apnea treatment preferences found to differ among patients and providers

A new study to be presented at the SLEEP 2025 annual meeting found that sleep medicine professionals favor continuous positive airway pressure therapy as treatment for comorbid obesity and obstructive sleep apnea, while patients lean toward treatment with tirzepatide.

Comorbid obesity and OSA treatment preferences found to differ among patients and providers

Sleep medicine professionals favour continuous positive airway pressure therapy as treatment for comorbid obesity and obstructive sleep apnoea (OSA), while patients lean toward treatment with tirzepatide, according to a study presented at the SLEEP 2025 annual meeting."The results highlight a need for real-world comparative effectiveness data of CPAP vs. tirzepatide, and a potential mismatch between patient and provider preferences when managing…